Biochemical, physiological, and pharmacological aspects of serotonin.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 13477804)

Published in Recent Prog Horm Res on January 01, 1957

Authors

S UDENFRIEND, P A SHORE, D F BOGDANSKI, H WEISSBACH, B B BRODIE

Articles by these authors

A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem (1952) 18.27

A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61

A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem (1960) 8.08

The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest (1955) 6.74

TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. J Biol Chem (1964) 5.40

Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J Biol Chem (1954) 5.08

A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med (1957) 5.04

The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. J Biol Chem (1955) 4.29

Identification and assay of serotonin in brain. J Pharmacol Exp Ther (1956) 4.17

The chemical estimation of tyrosine and tyramine. J Biol Chem (1952) 4.09

The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther (1957) 3.99

The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 3.60

A chemical method for the determination of free choline in plasma. J Biol Chem (1953) 3.57

ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. J Pharmacol Exp Ther (1965) 3.45

The estimation of 5-hydroxytryptamine (serotonin) in biological tissues. J Biol Chem (1955) 3.28

Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med (1960) 3.26

On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther (1959) 3.16

Some physico-chemical factors in drug action. J Pharm Pharmacol (1957) 3.13

Enzymatic hydroxylation of aromatic compounds. Arch Biochem Biophys (1956) 3.09

The fate of antipyrine in man. J Pharmacol Exp Ther (1950) 3.05

Serotonin release as a possible mechanism of reserpine action. Science (1955) 3.03

The direct determination of phosphatidyl ethanolamine and phosphatidyl serine in plasma and red blood cells. J Biol Chem (1953) 2.98

Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science (1960) 2.87

A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Am J Med (1956) 2.84

BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther (1965) 2.82

Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem (1954) 2.78

INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS. J Pharmacol Exp Ther (1965) 2.77

A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci (1957) 2.71

Aromatic L-amino acid decarboxylase. J Biol Chem (1962) 2.70

Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther (1958) 2.62

Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues. J Biol Chem (1959) 2.57

The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther (1950) 2.54

The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther (1957) 2.46

The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.38

Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther (1958) 2.37

Enzymatic metabolism of drugs and other foreign compounds. Annu Rev Biochem (1958) 2.36

Incorporation of C14-labeled amino acids into actinomycin and protein by Streptomyces antibioticus. J Biol Chem (1963) 2.29

Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther (1956) 2.26

A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20

Detoxication of drugs and other foreign compounds by liver microsomes. Science (1955) 2.20

Effect of iproniazid on serotonin metabolism in vivo. J Pharmacol Exp Ther (1957) 2.16

Estimation of intracellular water in man. Am J Physiol (1950) 2.14

The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. J Neurochem (1957) 2.13

Evidence that serotonin has a role in brain function. Science (1955) 2.13

Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther (1960) 2.10

The fate of thiopental in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1950) 2.10

A RAPID AND SIMPLE RADIOASSAY FOR TYROSINE HYDROXYLASE ACTIVITY. Anal Biochem (1964) 2.09

The enzymatic conversion of phenylalanine to tyrosine. J Biol Chem (1952) 2.09

A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine. J Biol Chem (1960) 2.08

Isolation and properties of crystalline cobamide coenzymes containing benzimidazole or 5, 6-dimethylbenzimidazole. J Biol Chem (1960) 2.07

Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (1955) 1.99

Assay, purification, and properties of the adenylocobamide coenzyme. J Biol Chem (1960) 1.94

CONVERSION OF PROLINE TO COLLAGEN HYDROXYPROLINE IN A CELL-FREE SYSTEM FROM CHICK EMBRYO. J Biol Chem (1963) 1.89

Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther (1957) 1.86

Absorption of drugs from the stomach. II. The human. J Pharmacol Exp Ther (1957) 1.85

Fluorescence characteristics of 5-hydroxytryptamine (serotonin). Science (1955) 1.84

Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate. J Pharmacol Exp Ther (1954) 1.78

Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines. J Biol Chem (1955) 1.77

The metabolic fate of phenylbutazone (butazolidin) in man. J Pharmacol Exp Ther (1955) 1.76

Isolation of gamma-aminobutyrylhistidine (homocarnosine) from brain. J Biol Chem (1961) 1.76

Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan. J Biol Chem (1957) 1.74

Preparation of C14 uniformly labeled fructose by means of photosynthesis and paper chromatography. Science (1949) 1.74

The purification and properties of beta-methylaspartase. J Biol Chem (1959) 1.70

ENZYMATIC HYDROXYLATION OF PROLINE IN MICROSOMAL POLYPEPTIDE LEADING TO FORMATION OF COLLAGEN. Proc Natl Acad Sci U S A (1965) 1.70

Release of inorganic tripolyphosphate from adenosine triphosphate during vitamin B-12 coenzyme biosynthesis. J Biol Chem (1963) 1.69

Further observations on patients with malignant carcinoid. Am J Med (1957) 1.69

5-Hydroxytryptophan decarboxylase: preparation and properties. J Biol Chem (1954) 1.66

Assay of L-phenylalanine as phenylethylamine after enzymatic decarboxylation; application to isotopic studies. J Biol Chem (1953) 1.65

The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia. J Biol Chem (1953) 1.64

Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther (1959) 1.63

The physiological disposition and metabolic fate of cortisone in man. J Clin Invest (1957) 1.62